Data is not available at this time.
Kanamic Network Co., Ltd. operates in Japan's healthcare information services sector, specializing in cloud-based systems that facilitate interdisciplinary collaboration in medical and elderly care. The company’s core revenue model revolves around subscription-based software solutions, including its flagship medical and elderly care communications system, which integrates care reporting, service calendars, and administrative functions. These offerings cater to in-home care providers, nursing facilities, and community support centers, streamlining workflows and improving care coordination. Kanamic also provides elderly care business management software tailored to different service classifications, alongside childcare support systems that enhance community-wide child-rearing initiatives. Beyond software, the company generates revenue through consulting, job placement, and educational services, as well as content production for healthcare professionals. Positioned as a niche player, Kanamic leverages Japan’s aging population and digitization trends in healthcare, differentiating itself through localized, user-friendly platforms. While it faces competition from larger healthcare IT providers, its focus on community-based care and interdisciplinary integration strengthens its market relevance.
Kanamic reported revenue of ¥5.01 billion for FY2024, with net income of ¥920 million, reflecting an 18.4% net margin. Operating cash flow stood at ¥1.51 billion, supported by recurring software subscriptions and efficient cost management. Capital expenditures were modest at ¥132 million, indicating a capital-light model focused on scalable cloud solutions. The company’s profitability metrics suggest disciplined operational execution in a specialized market.
Diluted EPS of ¥19.38 underscores Kanamic’s earnings capability, driven by high-margin software services and low debt reliance. The company’s capital efficiency is evident in its robust operating cash flow relative to revenue, with minimal reinvestment needs. This positions it well to fund organic growth or strategic initiatives without significant leverage.
Kanamic maintains a strong liquidity position, with ¥3.43 billion in cash and equivalents against ¥932 million in total debt. The debt-to-equity ratio appears conservative, reflecting a low-risk financial structure. Its balance sheet supports flexibility for R&D or acquisitions, though the company has historically prioritized organic expansion.
Growth is likely tied to Japan’s healthcare digitization and elderly care demand, though specific historical trends are undisclosed. The company pays a dividend of ¥6.5 per share, signaling a commitment to shareholder returns while retaining earnings for reinvestment. Dividend sustainability is supported by steady cash generation and a payout ratio below 40%.
At a market cap of ¥19.1 billion, Kanamic trades at a P/E of ~20.8x, aligning with niche healthcare IT peers. Its low beta (0.302) suggests defensive characteristics, though limited international exposure may cap growth expectations. Investors likely value its stable cash flows and demographic tailwinds.
Kanamic’s localized expertise and integrated care platforms provide a competitive edge in Japan’s fragmented healthcare IT market. Long-term prospects hinge on expanding its software suite and leveraging regulatory shifts toward digitized care coordination. Risks include reliance on domestic demand and potential margin pressure from larger entrants.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |